This Article supports SDG 3 by showing that a broad range of interventions for behaviours that challenge are efficacious for people with intellectual disability, but that effect sizes are small
This study supports SDG 3 by examining the incidence of stroke among people with disabilities, a group who are more likely to have risk factors for stroke. The incidence was found to be almost 2.5 times higher than in non-disabled people, and occuring 20 years earlier. Public health measures are urgently needed to address this problem.
The study evaluates the microbial quality of lettuce irrigated with wastewater from the Onyasia River.
Elsevier,
Artificial Intelligence in Clinical Practice, How AI Technologies Impact Medical Research and Clinics
2024, Pages 395-399
To harness the power and promise of AI in global health, adequate investment must be made in communication, computer systems, and supporting personnel to collect, curate, and manage the data necessary to enable benefits and minimize harm from the use of AI-related tools. In developed countries, this has either occurred or is underway. Developing countries run the risk of widening the digital divide if this does not occur. This chapter supports SDG3.
As we enter the ninth year since the adoption of the UN Sustainable Development Goals (SDGs) in 2015, the pressing need to meet these ambitious objectives becomes ever more evident.
Advance directives give people the right and agency to determine what treatment they should receive when they are unable to make such decisions during an episode of illness
Training interventions with psychodrama for formal caregivers of those with dementia
How Phonetic-phonological impairments reflect on each stage of the Alzheimer's Disease (AD)
PLCγ2 is genetically linked to Alzheimer’s disease (AD), but it is unclear how PLCγ2 contributes to pathology. Tsai et al. demonstrate that AD-associated PLCG2 variants bidirectionally orchestrate microglial responses to plaques and impact neural function in an AD mouse model. This positions PLCγ2 as a key microglial signaling node and shows that targeting PLCγ2 could have therapeutic benefits in AD.
The role of estrogen and ferroptosis in Alzheimer's disease is known. Ginseng has estrogen-like effects as well as a regulatory role in Alzheimer's disease and iron metabolism and this paper discusses for the frist time the link between ginseng, ferroptosis, and Alzheimer's disease.
